Medicine-Infectious Diseases

administers grant

1/2 REPRIEVE Extension for Trial Completion
1/2 REPRIEVE Extension for Trial Completion
A Mechanistic substudy of the effects of crizanlizumab and dapagliflozin on thrombosis and inflammation in COVID-19
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
A participant-derived xenograft mouse model to study T-cell-mediated viral control and mRNA vaccine strategies
A5332: Prevention of Vascular Events in HIV - REPRIEVE & Substudy A5333s: Pitavastatin on CAD & Infammatory Biomarkers
A5332: Prevention of Vascular Events in HIV - REPRIEVE & Substudy A5333s: Pitavastatin on CAD & Inflammatory Biomarkers
ACTG LOC: PF A5379 - Y3 Protocol co-Chair (1560 G YC257)
ACTG LOC: PF A5391 – Y2 Protocol co-Chair (1560)
ACTG LOC: PF Chair A5386 - Y3 Protocol co-Chair (1560 G YC266)
ACTG LOC: PF Chair A5418 - Protocol Chair
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections, ACTG LOC: PF A5357 - Y3 Protocol Vice Chair (1560)
AIDS Education and Training Centers Program
AIDS Malignancy Consortium (AMC) - AMC 099 Protocol Chair
AMC Domestic Site - Weill Cornell Medicine
Addgene 705011
Aging with HIV: Novel Biomarkers of Inflammation and Morbidity
Antibacterial Resistance Leadership Group (ARLG)
BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication
Bacteria and Host in TB Transmission
Bacterial Characteristics of Community-associated Carbapenem-Resistant Enterobacteriaceae
Bacterial and Host Heterogeneity in TB latency, persistence and progression
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir
CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation
CTL-Mediated Elimination of Replication Competent vs. Defective HIV Proviruses from Natural Latent Reservoirs: Roles of Antigen Specificity and Functional Characteristics
Characterization of Non-subtype B HIV-1 Reservoirs and its Association with Longitudinal Clinical Outcomes
Characterization of a Memory CD4+ T-cell Humanized Mouse Model for the Evaluation of Autologous Cell Therapies and Studies of HIV Persistence
Clonal Hematopoeisis in HIV and Aging
CoVPN 3001: Phase 3, SARS-CoV-2 Vaccine (Moderna TX, Inc.)
CoVPN 3004: Phase 3, SARS-CoV-2 Vaccine (Novavax)
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
Cost-effectiveness and Clinical Outcomes of Liver Disease Staging Evaluations in Chronic Hepatitis C Virus Infection: Strategies to Increase Hepatitis C Treatment Access
Cytological Profiling to Rapidly Predict Drug Mechanism of Action Against M.tuberculosis
Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia
Deciphering Mechanisms of HIV Latency Reversal in Perinatal Infection
Defining the mechanism of coma in cerebral malaria
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
Development of rabbit animal models of ventilator-associated bacterial pneumonia produced by carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
Effects of Glucocorticoids on Cognitive Functioning HIV-infected Women
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
Engineered CTL with Inducible Ab Secretion; a Tripartite attack on HIV Reservoirs
Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational Approach
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
Epidemiology and outcomes of serious injection-related infections in New York State
Epigenetic dysregulation of inflammation linked to longitudinal cardiac toxicity in perinatal HIV infection
Epigenetics of HIV, Aging, and Sleep Deficiency
Genetic Risk of HIV Acquisition: Mechanisms of Resilience
HIV Prevention Trials Network (HPTN 083 - NJMS)
HIV Prevention Trials Network (HPTN 083 FHI360 - WCM)
HIV Prevention Trials Network (HPTN 083 FHI360 - WCM)
HIV Vaccine Research and Development (INHCC)
HOPE - HIV Obstruction by Programmed Epigenetics
HOPE in Action
HPTN 083 - Viiv Funding
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer''s from HIV-Associated Cognitive Dysfunction
Harnessing single cell epigenome-wide profiling of myeloid cells to compare and contrast Alzheimer''s from HIV-associated cognitive dysfunction
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
Immunologic control of HIV-1 through combination bNAbs and biologics
Impact of Microbial Dysbiosis on MAIT Cell Tissue Repair Program after Acute HIV Infection
Impact of Treatment on Brain Integrity in the Earliest Stages of HIV Infection
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment
Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease Risk
Investigating the Impact of Race on Gene-Expression Profiles in HIV- Associated Neurocognitive Disorders
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG)
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - A5391
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - PF CRS 7803
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - PF CRS 7804
Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1
Measurement of HIV Proviral Reservoir Using Intact Proviral DNA Assay
Mechanisms of CTL Resistance in HIV Reservoirs
Metabolic determinants of Mtb virulence, vulnerability and variation - Core A
Metabolic determinants of Mtb virulence, vulnerability and variation - Core B
Metabolic determinants of Mtb virulence, vulnerability and variation - Project 2
Metabolic determinants of Mtb virulence, vulnerability and variation - Project 3
Metabolomics to identify synergistic TB targets
Mining the biochemical dark matter of M. tuberculosis by high-throughput CRISPRi
NK cell memory development in HIV acute infection and vaccination
Novel approaches for relating genetic variation in endogenous retroviruses to function and disease
Omics for TB: Response to Infection and Treatment
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Innovative Dosing Schedules of AmBisome for Treatment of Experimental Invasive Pulmonary Aspergillosis: Establishing a Preclinical Foundation for Improved Patient Care and Outcome
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) - A5332 substudy A5361s: Uptown Site 7803
Pitavastatin to Reduce Physical Function Impairment and FRailty in HIV (PREPARE) - A5332 substudy A5361s: 1560 B WB699
Predicting Infections in Neutropenic Hosts Receiving Fluoroquinolone Prophylaxis
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance and Other Adverse Events
Protocol MCA-1031 Agreement with Rockefeller University
REACH: Research Enterprise to Advance a Cure for HIV
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
Research Training in Infectious Diseases
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
Single-Cell Analysis of HIV-1 Production and Transmission
Supplement - AIDS Education and Training Centers Program
TARGETED CATALYTIC COMPLEMENT-ACTIVATING MOLECULES FOR TREATMENT OF EMERGING AND WHO PRIORITY BACTERIAL AND FUNGAL PATHOGENS
TBDR Mediated Cefiderocol Resistance in Psuedomonas
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
Targeting HIV reservoirs in the CNS with CAR/CXCR5 T cells for the long-term remission of HIV.
The Role of Transposable Elements in Healthy Aging and in Alzheimer''s Disease
The Transmission Biology of Mycobacterium Tuberculosis
The role of epigenetic transcriptional memory in monocyte-macrophage cells and cardiovascular disease risk
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
Tri-I Training Program in Metabolomics
Understanding Immune Evasion by HIV-1 Repliclones
Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium - -Expanding Diversity for Global Equity (EDGE) (VUMC 99377)
WMD ECHO Detector
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit
Weill Cornell Medicine Physician-Scientist Academy

VIVO Weill Cornell Medical College

Medicine-Infectious Diseases Academic Department

Research

administers grant